IFN-γ cytokines, and CD107a+ producing CD3+CD8+ T cells in the spleen and MLN were induced by the NC8-pSIP409-HA-DCpep in mouse models.
NC8-pSIP409-HA-DCpep provided 100% protection against the mouse-adapted H9N2 virus (H9N2 m-AV) and reduced virus replication in the lungs after challenge with H9N2 m-AV.
NC8-pSIP409-HA-DCpep induced strong T cell immune response in the PBMC in chickens.
IgG and sIgA were significantly induced by the NC8-pSIP409-HA-DCpep in chickens.
Oral vaccination with NC8-pSIP409-HA-DCpep induced protective immunity against H9N2 AIVs in chickens.